$1.01 -0.04 (-3.81%)
XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB)
Company News
XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com
XTL Biopharmaceuticals, an Israeli pharmaceutical company, announced the results of its Annual and Extraordinary General Meeting, including the re-election of board members and the appointment of independent auditors. The company also confirmed the acquisition of The Social Proxy Ltd., which will add two new directors to its board.
XTL Entered Definitive Agreement to Acquire The Social Proxy
expands its IP portfolio to AI Web Data
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day s...